Nilsine Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$887K Buy
9,674
+417
+5% +$36.5K 0.06% 244
2026
Q1
$779K Buy
9,257
+3,723
+67% +$332K 0.06% 240
2025
Q4
$437K Sell
5,534
-3,116
-36% -$244K 0.04% 290
2025
Q3
$691K Sell
8,650
-135
-2% -$11.5K 0.06% 245
2025
Q2
$799K Sell
8,785
-483
-5% -$44.1K 0.08% 222
2025
Q1
$868K Sell
9,268
-144
-2% -$12.9K 0.1% 198
2024
Q4
$856K Buy
9,412
+1,176
+14% +$112K 0.09% 203
2024
Q3
$855K Sell
8,236
-105
-1% -$10.7K 0.11% 187
2024
Q2
$809K Sell
8,341
-73
-0.9% -$6.73K 0.11% 187
2024
Q1
$758K Sell
8,414
-68
-0.8% -$5.76K 0.1% 192
2023
Q4
$676K Buy
8,482
+156
+2% +$11.7K 0.1% 198
2023
Q3
$592K Sell
8,326
-655
-7% -$49K 0.09% 205
2023
Q2
$692K Sell
8,981
-278
-3% -$21.5K 0.1% 197
2023
Q1
$696K Buy
+9,259
New +$688K 0.11% 194

Other funds holding CL

Nilsine Partners's CL Position: Q2 2026 in Review

Nilsine Partners increased its Colgate-Palmolive (CL) stake by 4.5% in Q2 2026, buying an estimated $36.5K and bringing the position to 9,674 shares worth $887K. The position accounts for 0.06% of the portfolio, ranked #244.

Nilsine Partners first reported a position in CL in Q1 2023 and has held it in 14 quarters since. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Nilsine Partners held 9,674 shares of Colgate-Palmolive worth $887K as of Q2 2026.
  • Nilsine Partners bought 417 Colgate-Palmolive shares in Q2 2026, an estimated $36.5K.
  • Colgate-Palmolive made up 0.06% of Nilsine Partners's portfolio in Q2 2026, its #244 holding.
  • Nilsine Partners first reported a position in Colgate-Palmolive in Q1 2023 and has held it in 14 quarters since.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.